issued
on 07 Jan 2025
Last Applicant/ Owned by
46701 Commerce Center Dr.
Plymouth
MI
48170
Serial Number
98324211 filed on 20th Dec 2023
Registration Number
N/A
Correspondent Address
J. Matthew Buchanan
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, na Read More
Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
N/A
N/A
No 98324211
No Service/Collective Mark
No 61932-US-NF2
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
07th Jan 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
26th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
26th Nov 2024 | PUBLISHED FOR OPPOSITION |
20th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
29th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
28th Oct 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
28th Oct 2024 | EXAMINERS AMENDMENT E-MAILED |
28th Oct 2024 | EXAMINER'S AMENDMENT ENTERED |
28th Oct 2024 | EXAMINERS AMENDMENT -WRITTEN |
22nd Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |